Summary: This study was conducted to investigate the eŠects of treatment with the prototypical inducers rifampicin (Rif), dexamethasone (Dex), and omeprazole (Ome) on the mRNA levels of drugmetabolizing enzymes in primary cultures of cryopreserved human, cynomolgus monkey, and rat hepatocytes. Analysis was performed by quantitative real-time RT-PCR using primers and TaqMan probes. Treatment with Ome substantially increased the mRNA levels of both CYP1A1 and CYP1A2 in human hepatocytes, but increased only the mRNA level of CYP1A1 in monkey hepatocytes, whereas it had no marked eŠect on the mRNA levels of CYP1A1 or CYP1A2 in rat hepatocytes. Treatment with Rif or Dex did not markedly aŠect the mRNA level of CYP1A in any of the hepatocyte cultures under the conditions used. All three inducers increased the mRNA level of CYP3A8 in monkey hepatocytes (in the order RifÀDexAEOme), and a similar proˆle was observed for the mRNA level of CYP3A4 in human hepatocytes, but the potency of induction was markedly attenuated. In contrast, only Dex substantially increased the mRNA level of CYP3A1 in rat hepatocytes, with Rif and Ome showing no eŠects. These results indicate that the molecular mechanisms responsible for the regulation of CYP1A2 genes diŠer between humans and cynomolgus monkeys, although the regulatory mechanisms for CYP1A1 and CYP3A genes are similar.
Introduction
Drug discovery and development depend greatly on the successful extrapolation of drug metabolism and toxicity data obtained from experimental animals to humans. It is therefore important to understand the similarities and diŠerences between experimental animals and humans in terms of the ‰uctuation proˆles of the cytochrome P450 (CYP) subfamilies following exposure to xenobiotics. From the viewpoint of data extrapolation, the monkey is a promising candidate for an experimental animal species because the monkey belongs to the order Primates, which also includes man. Various monkey species such as cynomolgus monkeys, rhesus monkeys, marmoset monkeys, and so on have been used in a wide variety of experiments. Among these species, cynomolgus monkeys have often been employed in studies of drug metabolism and toxicity.
Recently, we have been studying the changes in the mRNA levels of various drug-metabolizing enzymes in primary cultures of human and rat hepatocytes following treatment with prototypical inducers such as rifam- picin (Rif), dexamethasone (Dex), and omeprazole (Ome). Rif induces CYP3A4 in primary cultures of human hepatocytes, [1] [2] [3] while this drug is not an inducer of CYP3A in rat hepatocytes, [2] [3] [4] with the rat being the most commonly used laboratory animal species for toxicological studies. Dex is a potent inducer of CYP3A in rat hepatocytes, whereas it is a weak inducer of CYP3A in human hepatocytes. 3) Ome is a potent inducer of CYP1A in primary cultures of human hepatocytes. 5) Although various studies on the catalytic properties of CYP enzymes in cynomolgus monkey hepatocytes have been reported, 6, 7) there is little information available on the induction of CYP enzymes in cynomolgus monkey hepatocytes. In the present study, we conducted comparative experiments on the inducibility of CYP1A and CYP3A mRNAs by the prototypical inducers Rif, Dex, and Ome in primary cultures of cryopreserved human, cynomolgus monkey, and rat hepatocytes. Isolation of cynomolgus monkey hepatocytes: Perfusion of the cynomolgus monkey liver was performed according to the Seglen method with some modiˆca-tions. 8) Brie‰y, the liver was perfused with Ca 2＋ -free Hanks solution containing 0.6 mM EGTA at 379 C for 4 min and further perfused with Hanks solution containing 0.025z collagenase at 379 C for 6 min. Hepatocytes were dispersed from the perfused liver in ice-cold HEPES solution. Afterˆltration through gauze, the hepatocytes were separated from nonparenchymal cells by centrifugation at 50×g for 2 min at 49 C. The cells were washed and resuspended in HEPES solution three times, then washed with Williams' medium E containing 20z fetal bovine serum, 2.5z polyvinylpyrrolidone, and 2z bovine serum albumin 7) (with the pH adjusted to approximately 7.4 with NaHCO3). Finally, the cells were resuspended in the same medium and cell viability was determined by the trypan blue exclusion test. After the addition of dimethylsulfoxide (DMSO,ˆnal concentration of 10z) to the cell suspension, the cell density was approximately 1.5 to 2.5×10 7 viable cells W mL. The cynomolgus monkey hepatocytes were cryopreserved at -309 C for 40 min, at -809 C for 15 min, and then in liquid nitrogen until use.
Materials and Methods

Materials
Isolation of rat hepatocytes: Perfusion of the rat liver was performed according to the Seglen method 8) with some modiˆcations. 9, 10) The rat hepatocytes were cryopreserved at -309 C for 40 min, at -809 C for 15 min, and then in liquid nitrogen until use.
Monolayer culture of human and rat hepatocytes: Monolayer cultures of the cryopreserved human and rat hepatocytes were obtained according to the method of Nishimura et al. 9, 10) Human cell suspensions with viability rates of 91z to 94z and rat cell suspensions with viability rates of 88z to 92z, as assessed by the trypan blue exclusion test, were used for the experiments ( Table 1 ). The cells were used for experiments at 48 hr after inoculation.
Monolayer culture of cynomolgus monkey hepatocytes: Monolayer cultures of the cryopreserved cynomolgus monkey hepatocytes were obtained according to the method of Nishimura et al. 11) with some modiˆcations. The cryopreserved hepatocytes were suspended in Hepatocyte Culture Medium. The hepato-cytes were then centrifuged at 45×g for 3 min at 49 C and resuspended in the same medium. The number of cells was counted using a Coulter Counter (Beckman Coulter, Inc., Fullerton, CA). Cell suspensions with viability rates of 80z to 99z were used for the experiments ( Table 1) . The cell suspensions were diluted to aˆnal concentration of 2.5×10 5 viable cells W mL with Hepatocyte Culture Medium, and inocula of 1×10 5 viable cells W 0.4 mL W well were introduced into 24-well plates that had been coated with type I collagen. The cells were cultured for 3 hr after inoculation under 5z CO2 and 95z air at 379 C. The medium was then replaced with fresh medium, and the cells were cultured for 21 hr under 5z CO2 and 95z air at 379 C. The medium was then replaced with fresh medium without human epidermal growth factor (hEGF), hydrocortisone, gentamicin, and amphotericin B, and the cells were cultured for 24 hr under 5z CO2 and 95z air at 379 C. The cells were used for experiments at 48 hr after inoculation.
Experiments using primary cultures of human and cynomolgus monkey hepatocytes: In the induction studies, Hepatocyte Culture Medium without hEGF, hydrocortisone, gentamicin, and amphotericin B was used. The hepatocytes were exposed to the inducers Rif, Dex, and Ome (2, 10, and 50 mM each) for 24 hr. All inducers were dissolved in DMSO at aˆnal concentration of 0.1z (v W v). Controls were also exposed to DMSO at aˆnal concentration of 0.1z (v W v). Total RNA was extracted from the hepatocytes using the QIAshredder TM and RNeasy } Mini Kit. Experiments using primary cultures of rat hepatocytes: In the induction studies, Williams' medium E (pH 7.4) with 3z bovine serum albumin (fraction V) and without 10z fetal bovine serum, 4 mg W mL bovine insulin, 10 nM dexamethasone, 100 IU W mL penicillin, and 100 mg W mL streptomycin was used. The hepatocytes were exposed to the inducers Rif, Dex, and Ome (2, 10, and 50 mM each) or to vehicle for 24 hr as described above.
Oligonucleotides: The pairs of forward and reverse primers and the TaqMan probes for cynomolgus monkey b-actin, b-2-microglobulin (B2M), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), hypoxanthine phosphoribosyltransferase (HPRT), phosphoglycerate kinase (PGK), CYP1A1, CYP1A2, and CYP3A8 and for rat CYP1A1 used in the RT-PCR sequences were designed using Primer Express software (Applied Biosystems) ( Table 2) . Each primer and probe was homology searched by an NCBI BLAST search to ensure that it was speciˆc for the target mRNA transcript. The pairs of forward and reverse primers and the TaqMan probes for human b-actin, 12) CYP1A1, CYP1A2, and CYP3A4 11) and for rat b-actin, CYP1A2, and CYP3A1 13) used in the RT-PCR sequences have been reported previously. The primers and TaqMan probes were synthesized by Sigma-Aldrich Japan K.K. Genosys Division (Ishikari, Japan). The TaqMan probes contained 6-carboxy‰uorescein (FAM) at the 5? end and 6-carboxytetramethylrhodamine (TAMRA) at the 3? end and were designed to hybridize to a sequence located between the PCR primers. TaqMan RT-PCR conditions: Total RNA was diluted to about 4 mg W mL with 50 mg W mL yeast tRNA. The RT-PCR assay was performed in 50 mL of TaqMan One-Step RT-PCR Master Mix reagents containing 300 nM forward primer, 900 nM reverse primer, 200 nM TaqMan probe, and about 20 ng of total RNA according to the method described previously. 14, 15) The RT-PCR assay was performed using the ABI PRISM 7700 Sequence Detector system (Applied Biosystems) under the same conditions as in our previous studies. 14, 15) Statistical analysis: Data analyses were performed with the ABI PRISM Sequence Detector software. The relative expression of each mRNA was calculated as the DCt (the value obtained by subtracting the Ct value of b-actin mRNA from the Ct value of the target mRNA), as described in our previous reports. [14] [15] [16] [17] In particular, the amount of target mRNA relative to b-actin mRNA was expressed as 2 
Results
In the present study, the regulation of the mRNA expression of CYP1A and CYP3A in primary cultures of three lots each of cryopreserved human, cynomolgus monkey, and rat hepatocytes was investigated, and the mRNA expression levels in human, cynomolgus monkey, and rat hepatocytes were compared. The mRNA levels of b-actin as well as of several housekeeping genes were measured to conˆrm stable expression in human and rat hepatocytes under the same experimental conditions.
9) The ratios of B2M, GAPDH, HPRT, and PGK mRNA levels to the b-actin mRNA level in cynomolgus monkey hepatocytes were relatively constant from 48 to 72 hr of culture (Fig. 1A) . The ratios were not markedly changed in primary cultures of cynomolgus monkey hepatocytes following exposure to (Fig. 1B) . b-Actin mRNA was therefore employed as the endogenous control for the measurement of CYP mRNAs in the present study.
The ratio of CYP1A1 mRNA to b-actin mRNA in human hepatocytes fell to 42z of the initial level during theˆrst 24 hr, and the ratio then remained constant from 24 to 72 hr of culture ( Fig. 2A) . The ratio of CYP1A2 mRNA to b-actin mRNA in human hepatocytes fell to 4z of the initial level during theˆrst 24 hr, and the ratio then remained constant from 24 to 72 hr of culture (Fig. 2B) . The ratio of CYP1A1 mRNA to bactin mRNA in monkey hepatocytes fell to 5z of the initial level during theˆrst 24 hr, after which the ratio rose gradually, reaching 49z of the initial level at 72 h of culture (Fig. 2A) . The ratio of CYP1A2 mRNA to bactin mRNA in monkey hepatocytes fell to 0.7z of the initial level during theˆrst 24 hr and fell further to 0.05z at 72 hr of culture (Fig. 2B) . In contrast, the ratio of CYP1A1 mRNA to b-actin mRNA in rat hepatocytes at 72 hr of culture was 4700z of the initial level ( Fig. 2A) . The ratio of CYP1A2 mRNA to b-actin mRNA in rat hepatocytes fell to 2z of the initial level during theˆrst 24 hr and fell further to 0.2z at 72 hr of culture (Fig. 2B) . The ratio of CYP3A4 mRNA to bactin mRNA in human hepatocytes fell to 0.03z of the initial level at 72 hr of culture (Fig. 2C) . A similar trend was observed for CYP3A mRNA levels in monkey and rat hepatocytes. That is, the ratio of CYP3A8 mRNA to Fig. 1 . Changes in the mRNA levels of B2M, GAPDH, HPRT, and PGK during 72-hr primary culture of cynomolgus monkey hepatocytes (A) and eŠects of exposure to Rif, Dex, and Ome on the mRNA levels of housekeeping genes (B). Data are expressed as the ratio of the target mRNA to b-actin mRNA. Experiments (culture of cynomolgus monkey hepatocytes) were performed in triplicate using three monkey livers, and the values are shown as mean±SD (n＝3). In Fig. 1B , monkey hepatocytes were exposed to drugs at 48 hr after inoculation. The hepatocytes were treated with Rif, Dex, or Ome (2, 10, and 50 mM each) for 24 hr. The dotted line indicates the value for controls without DMSO, which was assigned a value of 1. b-actin mRNA in monkey hepatocytes and the ratio of CYP3A1 mRNA to b-actin mRNA in rat hepatocytes fell to 0.04z and 0.05z of the initial levels, respectively, at 72 hr of culture (Fig. 2C) .
We previously examined the eŠect of DMSO on the levels of human CYP mRNAs in primary cultures of cryopreserved human hepatocytes. 18) Because 0.1z DMSO did not aŠect the CYP mRNA level, the same concentration of DMSO was employed in the present study. Treatment of human and cynomolgus monkey hepatocytes with Rif and Dex did not have any marked eŠects on the mRNA levels of CYP1A1 or CYP1A2 under the conditions employed (Fig. 3A and B, top and middle panels). Only Ome substantially increased the mRNA levels of CYP1A1 in a concentration-dependent manner in both human and monkey hepatocytes (Fig. 3A, top and middle panels) . Interestingly, Ome also signiˆcantly increased the mRNA level of CYP1A2 in human hepatocytes (Fig. 3B, top panel) , whereas it did not aŠect the mRNA level of CYP1A2 in monkey hepatocytes (Fig. 3B, middle panel) . Treatment with Dex and Ome also tended to increase the mRNA level of Fig. 3 . EŠects of drug exposure on the mRNA levels of CYP1A1 (A), CYP1A2 (B), and CYP3As (C) in primary cultures of human, cynomolgus monkey, and rat hepatocytes. Data are expressed as the ratio of the target mRNA to b-actin mRNA. Experiments (culture of human, cynomolgus monkey, and rat hepatocytes) were performed in triplicate using three livers each, and the values are shown as mean±SD (n＝3). Hepatocytes were exposed to drugs at 48 hr after inoculation. The hepatocytes were treated with Rif, Dex, or Ome (2, 10, and 50 mM each) for 24 hr. The dotted line indicates the value for controls without DMSO, which was assigned a value of 1. *pº0.05, **pº0.01 and ***pº0.001 vs. controls at 0.1z DMSO.
CYP1A1 in rat hepatocytes, but in a concentrationindependent manner (Fig. 3A, bottom panel) . As for CYP3A, Rif markedly increased the mRNA levels in a concentration-dependent manner in human and monkey hepatocytes (Fig. 3C, top and middle panels) . Dex and Ome also increased the mRNA levels of CYP3A4 in human hepatocytes and of CYP3A8 in monkey hepatocytes, but to lesser extent as compared with the eŠects of Rif (Fig. 3C, top and middle panels) . In rat hepatocytes, only Dex showed a tendency to increase the mRNA level of CYP3A1, but in a concentrationindependent manner (Fig. 3C, bottom panel) .
Discussion
In the present study, we compared the eŠects of treatment with Rif, Dex, and Ome on the levels of CYP1A and CYP3A mRNAs in primary cultures of hepatocytes obtained from humans, cynomolgus monkeys, and rats. We found several interesting diŠerences with regard to the changes in the mRNA levels of CYP1A and CYP3A between cynomolgus monkey hepatocytes and hepatocytes from the other sources examined.
In the human liver, CYP1A2 is constitutively expressed, but CYP1A1 is infrequently expressed. 19) We also reported that the expression level of CYP1A1 mRNA was much lower than that of CYP1A2 mRNA 20) in the human liver. Human CYP1A2 exhibits higher activity for methoxyresoruˆn O-demethylation (MROD) than for ethoxyresoruˆn O-deethylation (EROD). 21) In contrast, Sakuma et al. 22) reported that the expression level of CYP1A1 mRNA was higher than that of CYP1A2 mRNA in the cynomolgus monkey liver. Furthermore, hepatic microsomal MROD activity was reported to be lower than EROD activity in the cynomolgus monkey. 23) We also conˆrmed in the present study that the expression level of CYP1A2 mRNA was much lower than that of CYP1A1 mRNA in hepatocytes from cynomolgus monkeys. Furthermore, we found that CYP1A1 mRNA in cynomolgus monkey hepatocytes was substantially induced by treatment with Ome, the proˆle of which is similar to that of CYP1A1 and CYP1A2 in human hepatocytes.
The aromatic hydrocarbon receptor (AHR) is a ligand-activated transcription factor that controls the CYP1A1 and CYP1A2 genes. 24) Ome wasˆrst reported to enhance the nuclear uptake of the human AHR and to activate the transcription of a human CYP1A1-luciferase chimeric gene in HepG2 cells. 25) Ome is thought to activate the AHR to translocate into the nucleus, where the AHR-AHR nuclear translocator (ARNT) complex interacts with the xenobiotic responsive element (XRE) on the CYP1A1 5?-‰anking gene to activate transcription. 25, 26) Theseˆndings indicate that Ome enhances CYP1A gene transcription via activation of the AHR.
Quattrochi et al. 27) and Fernandez-Salguero et al. 28) reported the involvement of the AHR in the regulation of CYP1A2 expression. In the present study, Ome increased only CYP1A1 mRNA but not CYP1A2 mRNA in monkey hepatocytes, while it induced both CYP1A1 and CYP1A2 mRNAs in human hepatocytes.
In rat hepatocytes, neither CYP1A1 nor CYP1A2 mRNA levels were substantially changed following Ome exposure. Backlund et al. 29) reported that the induction of CYP1A1 in rat hepatoma H4IIE cells required high concentrations of Ome. This diŠerence in the response of CYP1A gene expression following treatment with Ome may be due to diŠerences in sensitivity (ligand a‹nity) and W or speciˆcity for the AHR between the animal species examined. However, this cannot explain the diŠerence in the response to Ome between CYP1A1 and CYP1A2 genes in the cynomolgus monkey. It seems likely that the mechanism for the transcriptional activation of the CYP1A2 gene diŠers from that of the CYP1A1 gene in the cynomolgus monkey.
It has been proposed that the pregnane X receptor (PXR) forms a heterodimer with the retinoid X receptor a (RXRa), playing an important role in CYP3A4 gene regulation for several xenobiotics such as Rif in humans. 30, 31) Pascussi et al. 32) observed that Dex increased both RXRa and PXR mRNA expression levels through glucocorticoid receptor (GR)-mediated activation, whereas PXR activators such as Rif did not. Several lines of evidence suggest that the regulation of CYP3A4 gene expression in human hepatocytes by glucocorticoids occurs through two distinct mechanisms involving the GR:ˆrst, by controlling the expression of the PXR and the constitutive androstane receptor (CAR) under physiological conditions through the classical GR pathway, and second, by activating the PXR under bolus or stress conditions. 33) The molecular basis for species diŠerences in CYP3A induction by xenobiotics has already been reported. 34, 35) It has also been reported that the ligand binding domains of monkey PXR show close similarity to those in humans. 36) In the present study, both Rif and Dex increased CYP3A mRNA levels in human and cynomolgus monkey hepatocytes, with Rif being the more potent inducer. In rat hepatocytes, however, among the three compounds examined, only Dex increased the CYP3A1 mRNA level, and the eŠect of Rif was negligible as compared with that of Dex (Fig. 3) . This may be due to diŠerences in the sensitivity (ligand a‹nity) and W or speciˆcity for these nuclear receptors between primates and rodents, which is in accord with the previouŝ ndings. [34] [35] [36] We observed in the present study that cynomolgus monkey CYP3A8 mRNA and human CYP3A4 mRNA showed similar elevation proˆles in primary cultures of hepatocytes treated with the inducers. Ohmori et al. 37) estimated that CYP3A8 accounts for 20z of the total CYP in liver microsomes from untreated cynomolgus monkeys, which is comparable to the levels of CYP3A4 accounting for about 30z of the total CYP in human liver microsomes. 38) We therefore consider that the cynomolgus monkey is a good animal model for evaluating the induction of CYP3A in preclinical studies.
The results of the present study clearly demonstrated that following treatment of hepatocytes with the prototypical inducers Rif, Dex, and Ome, the response proˆles of CYP1A2 mRNA levels are diŠerent but those of CYP1A1 and CYP3A mRNA levels are similar between cynomolgus monkeys and humans. These characteristics of the cynomolgus monkey should be taken into consideration when this animal species is employed in studies on drug metabolism and toxicity.
In summary, we examined the eŠects of treatment with Rif, Dex, and Ome on the mRNA levels of CYP1A and CYP3A enzymes in primary cultures of human, cynomolgus monkey, and rat hepatocytes. Of the three inducers examined, Ome substantially increased the mRNA levels of both CYP1A1 and CYP1A2 in human hepatocytes but of only CYP1A1 in monkey hepatocytes. Treatment with Rif, Dex, and Ome increased the mRNA levels of CYP3A4 in human hepatocytes and of CYP3A8 in monkey hepatocytes, but not of CYP3A1 in rat hepatocytes. In contrast, treatment with Dex markedly increased the mRNA level of CYP3A1 in rat hepatocytes, but not of CYP3A4 in human hepatocytes or of CYP3A8 in monkey hepatocytes. These results indicate that the molecular mechanisms for the regulation of CYP1A2 genes diŠer between humans and cynomolgus monkeys, although the regulation mechanisms of CYP1A1 and CYP3A genes are similar.
